Nootropics

Cerebrolysin: molecular data, studies & sources

Cerebrolysin is catalogued here as an identity or preparation requiring extra specification. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked 2026-09-21 · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular record not yet resolved

Cerebrolysin is a peptide and amino-acid preparation, not one discrete molecule. Clinical findings concern the studied preparation.

MF: not assigned · MW: not assigned · Structure: not assigned

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

Human study · PubMed trial index
Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.
Panisset M, Gauthier S, Moessler H et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2002
PMID 12111446 · DOI: 10.1007/s007020200092
Human study · PubMed trial index
Prospective Randomized Control Trial to Compare the Role of Injection Cerebrolysin for 10 Days Duration Against Placebo in Operated Cases of Degenerative Cervical Myelopathy.
Sharma A, Agrawal H, Naseem A et al. · Spine · 2023
PMID 36730671 · DOI: 10.1097/BRS.0000000000004542
Human study · PubMed trial index
Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.
Khasanova DR, Kalinin MN · BMC neurology · 2023
PMID 36973684 · DOI: 10.1186/s12883-023-03159-w
Human study · PubMed trial index
The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury.
Birle C, Slavoaca D, Muresanu I et al. · Journal of medicine and life · 2020
PMID 33072197 · DOI: 10.25122/jml-2020-0146
Human study · PubMed trial index
Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke.
Bajenaru O, Tiu C, Moessler H et al. · Journal of medicine and life · 2010
PMID 20968198

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

Review · secondary evidence
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE, Abakumova T, Vernay L et al. · The Cochrane database of systematic reviews · 2017
PMID 28430363 · DOI: 10.1002/14651858.CD007026.pub5
Review · secondary evidence
Cerebrolysin for vascular dementia.
Cui S, Chen N, Yang M et al. · The Cochrane database of systematic reviews · 2019
PMID 31710397 · DOI: 10.1002/14651858.CD008900.pub3

Cerebrolysin supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

Compare all Cerebrolysin sizes, forms and supplier prices →

Supplier	Recorded packages	Example source listing
Cenexa LabsUSD	60mg Vial1 recorded offers	60mg Vial · $62.99Checked Sep 16, 2026Supplier listing
Modified AminosUSD	60mg Vial1 recorded offers	60mg Vial · $69.99Checked Sep 16, 2026Supplier listing

Reference sources & further reading

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Search for additional research

These links run searches; their results have not been individually reviewed and can include unrelated compounds.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.